Your browser doesn't support javascript.
loading
Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis.
Gao, Ya; Chen, Yamin; Liu, Ming; Niu, Mingming; Song, Ziwei; Yan, Meili; Tian, Jinhui.
Afiliação
  • Gao Y; Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou730000, China.
  • Chen Y; Evidence-Based Nursing Center, School of Nursing, Lanzhou University, Lanzhou730000, China.
  • Liu M; Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou730000, China.
  • Niu M; Evidence-Based Nursing Center, School of Nursing, Lanzhou University, Lanzhou730000, China.
  • Song Z; Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou730000, China.
  • Yan M; Evidence-Based Nursing Center, School of Nursing, Lanzhou University, Lanzhou730000, China.
  • Tian J; Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou730000, China.
Epidemiol Infect ; 149: e66, 2021 02 15.
Article em En | MEDLINE | ID: mdl-33583450
ABSTRACT
Coronavirus disease 2019 (COVID-19) has become a global pandemic. Previous studies showed that comorbidities in patients with COVID-19 are risk factors for adverse outcomes. This study aimed to clarify the association between nervous system diseases and severity or mortality in patients with COVID-19. We performed a systematic literature search of four electronic databases and included studies reporting the prevalence of nervous system diseases in COVID-19 patients with severe and non-severe disease or among survivors and non-survivors. The included studies were pooled into a meta-analysis to calculate the odds ratio (OR) with 95% confidence intervals (95%CI). We included 69 studies involving 17 879 patients. The nervous system diseases were associated with COVID-19 severity (OR = 3.19, 95%CI 2.37 to 4.30, P < 0.001) and mortality (OR = 3.75, 95%CI 2.68 to 5.25, P < 0.001). Specifically, compared with the patients without cerebrovascular disease, patients with cerebrovascular disease infected with COVID-19 had a higher risk of severity (OR = 3.10, 95%CI 2.21 to 4.36, P < 0.001) and mortality (OR = 3.45, 95% CI 2.46 to 4.84, P < 0.001). Stroke was associated with severe COVID-19 disease (OR = 1.95, 95%CI 1.11 to 3.42, P = 0.020). No significant differences were found for the prevalence of epilepsy (OR = 1.00, 95%CI 0.42 to 2.35, P = 0.994) and dementia (OR = 2.39, 95%CI 0.55 to 10.48, P = 0.247) between non-severe and severe COVID-19 patients. There was no significant association between stroke (OR = 1.79, 95%CI 0.76 to 4.23, P = 0.185), epilepsy (OR = 2.08, 95%CI 0.08 to 50.91, P = 0.654) and COVID-19 mortality. In conclusion, nervous system diseases and cerebrovascular disease were associated with severity and mortality of patients with COVID-19. There might be confounding factors that influence the relationship between nervous system diseases and COVID-19 severity as well as mortality.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / Demência / Epilepsia / COVID-19 Tipo de estudo: Etiology_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / Demência / Epilepsia / COVID-19 Tipo de estudo: Etiology_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article